BSE Live
Jan 02, 16:01Prev. Close
0.75
Open Price
0.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Cash Flow of Remedium Lifecare (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.38 | 0.01 | 0.02 | 0.00 | 0.01 | |
| Net CashFlow From Operating Activities | -0.20 | -0.07 | -0.16 | 0.07 | -1.36 | |
| Net Cash Used In Investing Activities | -0.24 | 1.06 | 0.02 | 0.09 | 1.48 | |
| Net Cash Used From Financing Activities | 0.29 | 0.08 | 0.00 | 0.00 | -0.11 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.15 | 1.06 | -0.14 | 0.15 | 0.00 | |
| Cash And Cash Equivalents Begin of Year | 1.08 | 0.02 | 0.16 | 0.01 | 0.01 | |
| Cash And Cash Equivalents End Of Year | 0.93 | 1.08 | 0.02 | 0.16 | 0.01 |
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017